Gvoke is premixed, prefilled and premeasured for pediatric and adult patients with diabetes ages 2 years and above to treat severe hypoglycemia. It is ready to use and room temperature stable. Gvoke PFS can be administered in 2 steps in the event of severe hypoglycemia. Available in 2 doses: a 0.5 mg/0.1 mL dose for pediatric patients and a 1.0 mg/0.2 mL dose for adolescent and adult patients.
For complete information, visit Xeris Biopharma
1 mL for 0.5 mg dose | 2 mL for 1.0mg dose
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or healthcare provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit diabeteseducator.org/Find.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.